Related Experiment Videos
[Adverse drug reactions in the elderly]
1Thérapeutique Médecine gériatrique, CHU de Rouen.
Bulletin De L'Academie Nationale De Medecine
|June 2, 2006
Summary
Elderly patients experience more frequent and severe adverse drug reactions (ADRs). Proactive prevention strategies, including better drug evaluation and improved information for healthcare professionals and patients, are crucial to mitigate these risks.
Area of Science:
- Geriatric pharmacology
- Drug safety and pharmacovigilance
Context:
- Elderly patients (>65 years) exhibit increased susceptibility to adverse drug reactions (ADRs).
- ADRs in this population often present with atypical signs and symptoms.
- Commonly implicated drug classes include cardiovascular, psychotropic, anticoagulant, and nonsteroidal anti-inflammatory drugs.
Purpose:
- To highlight the increased frequency and severity of ADRs in the elderly.
- To identify inherent and modifiable risk factors contributing to ADRs in older adults.
- To advocate for a proactive prevention policy addressing the human and economic burden of ADRs.
Summary:
- Aging-related physiological changes and external factors, including drug properties and healthcare provider/patient behavior, contribute to ADRs.
- Preventable risk factors underscore the need for targeted interventions.
- The significant impact of ADRs necessitates urgent preventive measures.
Impact:
- Enhanced drug evaluation tailored to the elderly population is essential.
- Improved dissemination of information to healthcare professionals and patients can reduce ADR incidence.
- Implementing proactive prevention policies will mitigate the substantial human and economic costs associated with ADRs in the elderly.